The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer

BackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Instit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qianxue Wu, Xin Tang, Wenming Zhu, Qing Li, Xiang Zhang, Hongyuan Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/aa2062e4e0464395893493d2337d248b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa2062e4e0464395893493d2337d248b
record_format dspace
spelling oai:doaj.org-article:aa2062e4e0464395893493d2337d248b2021-11-15T05:20:51ZThe Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer2234-943X10.3389/fonc.2021.751430https://doaj.org/article/aa2062e4e0464395893493d2337d248b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.751430/fullhttps://doaj.org/toc/2234-943XBackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium) were validated using datasets from METABRIC (Molecular Taxonomy of Breast Cancer International Consortium). Kaplan-Meier analysis and ROC (receiver operating characteristic) curve analysis were performed to explore the prognosis of candidate genes. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis were performed on the suspected candidate genes. Single-cell RNA-seq (scRNA-seq) data from GSE118389 were used to analyze the cell clusters in which OBFC2A (Oligosaccharide-Binding Fold-Containing Protein 2A) was mainly distributed. TIMER (Tumor Immune Estimation Resource) was used to verify the correlation between OBFC2A expression and immune infiltration. Clone formation assays and wound healing assays were used to detect the role of OBFC2A expression on the proliferation, invasion, and migration of breast cancer cells. Flow cytometry was used to analyze the effects of silencing OBFC2A on breast cancer cell cycle and apoptosis.ResultsSix candidate proteins were found to be differentially expressed in non-TNBC and TNBC groups from CPTAC. However, only OBFC2A was identified as an independently poor prognostic gene marker in METABRIC (HR=3.658, 1.881-7.114). And OBFC2A was associated with immune functions in breast cancer. Biological functional experiments showed that OBFC2A might promote the proliferation and migration of breast cancer cells. The inhibition of OBFC2A expression blocked the cell cycle in G1 phase and inhibited the transformation from G1 phase to S phase. Finally, downregulation of OBFC2A also increased the total apoptosis rate of cells.ConclusionOn this basis, OBFC2A may be a potential prognostic biomarker for TNBC.Qianxue WuXin TangWenming ZhuQing LiXiang ZhangHongyuan LiFrontiers Media S.A.articleOBFC2Atriple-negative breast cancerprognosisoverall survivalmolecular biologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic OBFC2A
triple-negative breast cancer
prognosis
overall survival
molecular biology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle OBFC2A
triple-negative breast cancer
prognosis
overall survival
molecular biology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Qianxue Wu
Xin Tang
Wenming Zhu
Qing Li
Xiang Zhang
Hongyuan Li
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
description BackgroundPatients with triple-negative breast cancer (TNBC) have poor overall survival. The present study aimed to investigate the potential prognostics of TNBC by analyzing breast cancer proteomic and transcriptomic datasets.MethodsCandidate proteins selected from CPTAC (the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium) were validated using datasets from METABRIC (Molecular Taxonomy of Breast Cancer International Consortium). Kaplan-Meier analysis and ROC (receiver operating characteristic) curve analysis were performed to explore the prognosis of candidate genes. GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis were performed on the suspected candidate genes. Single-cell RNA-seq (scRNA-seq) data from GSE118389 were used to analyze the cell clusters in which OBFC2A (Oligosaccharide-Binding Fold-Containing Protein 2A) was mainly distributed. TIMER (Tumor Immune Estimation Resource) was used to verify the correlation between OBFC2A expression and immune infiltration. Clone formation assays and wound healing assays were used to detect the role of OBFC2A expression on the proliferation, invasion, and migration of breast cancer cells. Flow cytometry was used to analyze the effects of silencing OBFC2A on breast cancer cell cycle and apoptosis.ResultsSix candidate proteins were found to be differentially expressed in non-TNBC and TNBC groups from CPTAC. However, only OBFC2A was identified as an independently poor prognostic gene marker in METABRIC (HR=3.658, 1.881-7.114). And OBFC2A was associated with immune functions in breast cancer. Biological functional experiments showed that OBFC2A might promote the proliferation and migration of breast cancer cells. The inhibition of OBFC2A expression blocked the cell cycle in G1 phase and inhibited the transformation from G1 phase to S phase. Finally, downregulation of OBFC2A also increased the total apoptosis rate of cells.ConclusionOn this basis, OBFC2A may be a potential prognostic biomarker for TNBC.
format article
author Qianxue Wu
Xin Tang
Wenming Zhu
Qing Li
Xiang Zhang
Hongyuan Li
author_facet Qianxue Wu
Xin Tang
Wenming Zhu
Qing Li
Xiang Zhang
Hongyuan Li
author_sort Qianxue Wu
title The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
title_short The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
title_full The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
title_fullStr The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
title_full_unstemmed The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
title_sort potential prognostic role of oligosaccharide-binding fold-containing protein 2a (obfc2a) in triple-negative breast cancer
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/aa2062e4e0464395893493d2337d248b
work_keys_str_mv AT qianxuewu thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT xintang thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT wenmingzhu thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT qingli thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT xiangzhang thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT hongyuanli thepotentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT qianxuewu potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT xintang potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT wenmingzhu potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT qingli potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT xiangzhang potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
AT hongyuanli potentialprognosticroleofoligosaccharidebindingfoldcontainingprotein2aobfc2aintriplenegativebreastcancer
_version_ 1718428635520565248